Cargando…
Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos
BACKGROUND: Insulin resistance (IR) is a state prior to the development of type 2 diabetes (T2D) and it is reversible with lifestyle modification. However, it is underdiagnosed due to the difficulty in its measurement. OBJECTIVE: To evaluate the diagnostic performance of the FINDRISC questionnaire t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Mexicano del Seguro Social
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395935/ https://www.ncbi.nlm.nih.gov/pubmed/36542467 |
_version_ | 1785083690048552960 |
---|---|
author | Varela-Vega, Yuline Roy-García, Ivonne Analí Pérez-Rodríguez, Marcela Velázquez-López, Lubia |
author_facet | Varela-Vega, Yuline Roy-García, Ivonne Analí Pérez-Rodríguez, Marcela Velázquez-López, Lubia |
author_sort | Varela-Vega, Yuline |
collection | PubMed |
description | BACKGROUND: Insulin resistance (IR) is a state prior to the development of type 2 diabetes (T2D) and it is reversible with lifestyle modification. However, it is underdiagnosed due to the difficulty in its measurement. OBJECTIVE: To evaluate the diagnostic performance of the FINDRISC questionnaire to identify IR. MATERIAL AND METHODS: An analytical cross-sectional study was performed in adults aged 20 to 60 years without previous diagnosis of T2D. Those using steroids and pregnant women were excluded. IR was diagnosed through the Triglycerides/glucose index. A ROC curve was used to establish the cut-off point for the diagnosis of IR. Sensitivity, specificity, predictive values and likelihood ratios were calculated. Risk measurement for IR was performed with the FINDRISC instrument. RESULTS: A total of 253 participants were included, with a prevalence of IR of 60.8%. The area under the curve of the FINDRISC instrument was 0.813 (95% confidence interval [95% CI] 0.759-0.865), with a cut-off point of 8. Sensitivity was 94.8% and specificity was 48.5%, positive predictive value was 74% and negative 86%, with a positive likelihood ratio of 1.84 and a negative of 0.11. CONCLUSIONS: The FINDRISC instrument is a useful screening tool to identify subjects with IR at the first level of care. A score ≥ 8 identifies subjects with IR |
format | Online Article Text |
id | pubmed-10395935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Instituto Mexicano del Seguro Social |
record_format | MEDLINE/PubMed |
spelling | pubmed-103959352023-08-04 Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos Varela-Vega, Yuline Roy-García, Ivonne Analí Pérez-Rodríguez, Marcela Velázquez-López, Lubia Rev Med Inst Mex Seguro Soc Aportación Original BACKGROUND: Insulin resistance (IR) is a state prior to the development of type 2 diabetes (T2D) and it is reversible with lifestyle modification. However, it is underdiagnosed due to the difficulty in its measurement. OBJECTIVE: To evaluate the diagnostic performance of the FINDRISC questionnaire to identify IR. MATERIAL AND METHODS: An analytical cross-sectional study was performed in adults aged 20 to 60 years without previous diagnosis of T2D. Those using steroids and pregnant women were excluded. IR was diagnosed through the Triglycerides/glucose index. A ROC curve was used to establish the cut-off point for the diagnosis of IR. Sensitivity, specificity, predictive values and likelihood ratios were calculated. Risk measurement for IR was performed with the FINDRISC instrument. RESULTS: A total of 253 participants were included, with a prevalence of IR of 60.8%. The area under the curve of the FINDRISC instrument was 0.813 (95% confidence interval [95% CI] 0.759-0.865), with a cut-off point of 8. Sensitivity was 94.8% and specificity was 48.5%, positive predictive value was 74% and negative 86%, with a positive likelihood ratio of 1.84 and a negative of 0.11. CONCLUSIONS: The FINDRISC instrument is a useful screening tool to identify subjects with IR at the first level of care. A score ≥ 8 identifies subjects with IR Instituto Mexicano del Seguro Social 2023 /pmc/articles/PMC10395935/ /pubmed/36542467 Text en © 2023 Revista Médica del Instituto Mexicano del Seguro Social. https://creativecommons.org/licenses/by-nc-nd/4.0/Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional. |
spellingShingle | Aportación Original Varela-Vega, Yuline Roy-García, Ivonne Analí Pérez-Rodríguez, Marcela Velázquez-López, Lubia Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos |
title | Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos |
title_full | Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos |
title_fullStr | Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos |
title_full_unstemmed | Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos |
title_short | Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos |
title_sort | certeza diagnóstica del instrumento findrisc para identificar resistencia a la insulina en adultos |
topic | Aportación Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395935/ https://www.ncbi.nlm.nih.gov/pubmed/36542467 |
work_keys_str_mv | AT varelavegayuline certezadiagnosticadelinstrumentofindriscparaidentificarresistenciaalainsulinaenadultos AT roygarciaivonneanali certezadiagnosticadelinstrumentofindriscparaidentificarresistenciaalainsulinaenadultos AT perezrodriguezmarcela certezadiagnosticadelinstrumentofindriscparaidentificarresistenciaalainsulinaenadultos AT velazquezlopezlubia certezadiagnosticadelinstrumentofindriscparaidentificarresistenciaalainsulinaenadultos |